Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH
Clinical trial NCT02390232 · COMPLETED
Trial details
- NCT number
- NCT02390232
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-11-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.